Skip to main content
. 2022 Mar 25;14:848991. doi: 10.3389/fnagi.2022.848991

FIGURE 1.

FIGURE 1

Analysis of brain homogenates by PMCA. Wb of the 3rd and 6th PMCA rounds are shown. After 6 rounds of amplification, PrPres was detected in the brains of (A) 5/7 MM1, (B) 2/3 MM2C, (C) 2/2 MM2T, (D) 3/3MV1, (E) 5/6 MV2, (F) 0/1 VV1, and (G) 4/4 VV2, although with variable efficiency. (H) No PrPres was amplified from the brain of OND patients (AD and FTD). (A–C) In particular, type 2 PrPres with a prevalence of the di-glycosylated species was generated by the BHs of 4/7 MM1, 2/3 MM2C and 2/2 MM2T patients, except for one MM1 patient (7_BH) in which the presence of a type 1 PrPres with an equal representation of the di- and mono-glycosylated band was observed. (D–G) In contrast, type 1 PrPres was generated by BHs of 3/3 MV1, 5/6 MV2 patients and 4/4 VV2 patients. Except for 2 VV2 samples (25_BH and 26_BH), all amplified PrPres were characterized by a prevalent di-glycosylated band. Numbers in the right of each Wb indicate the molecular weight marker.